| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aadi Bioscience Inc (NASDAQ: AADI)
AADI Technical Analysis
5
| As on 9th Jun 2023 AADI STOCK Price closed @ 8.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.63 & Strong Sell for SHORT-TERM with Stoploss of 20.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AADISTOCK Price
| Open | 8.23 | Change | Price | % |
| High | 8.31 | 1 Day | -0.06 | -0.74 |
| Low | 8.03 | 1 Week | 0.10 | 1.25 |
| Close | 8.10 | 1 Month | 0.10 | 1.25 |
| Volume | 73800 | 1 Year | -16.96 | -67.68 |
| 52 Week High 25.85 | 52 Week Low 6.85 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AADI Daily Charts |
AADI Intraday Charts |
Whats New @ Bazaartrend |
AADI Free Analysis |
|
|
AADI Important Levels Intraday
| RESISTANCE | 8.64 |
| RESISTANCE | 8.47 |
| RESISTANCE | 8.36 |
| RESISTANCE | 8.25 |
| SUPPORT | 7.95 |
| SUPPORT | 7.84 |
| SUPPORT | 7.73 |
| SUPPORT | 7.56 |
AADI Forecast May 2024
| 4th UP Forecast | 23.92 |
| 3rd UP Forecast | 18.85 |
| 2nd UP Forecast | 15.71 |
| 1st UP Forecast | 12.57 |
| 1st DOWN Forecast | 3.63 |
| 2nd DOWN Forecast | 0.49 |
| 3rd DOWN Forecast | -2.65 |
| 4th DOWN Forecast | -7.72 |
AADI Weekly Forecast
| 4th UP Forecast | 13.21 |
| 3rd UP Forecast | 11.57 |
| 2nd UP Forecast | 10.56 |
| 1st UP Forecast | 9.54 |
| 1st DOWN Forecast | 6.66 |
| 2nd DOWN Forecast | 5.64 |
| 3rd DOWN Forecast | 4.63 |
| 4th DOWN Forecast | 2.99 |
AADI Forecast2024
| 4th UP Forecast | 45.1 |
| 3rd UP Forecast | 33.23 |
| 2nd UP Forecast | 25.9 |
| 1st UP Forecast | 18.56 |
| 1st DOWN Forecast | -2.36 |
| 2nd DOWN Forecast | -9.7 |
| 3rd DOWN Forecast | -17.03 |
| 4th DOWN Forecast | -28.9 |
Aadi Bioscience Inc ( NASDAQ USA Symbol : AADI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AADI Business Profile
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, ABI-009 (FYARRO) is a form of sirolimus bound to albumin. Aadi is evaluating ABI-009 in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was founded in 2011 and is headquartered in Pacific Palisades, California. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service